CMA fines pharma companies for anticompetitive agreements

For only the second time, the UK's Competition and Markets Authority has secured compensation for the UK’s National Health Service, as a pharmaceutical company admitted to participating in an illegal market-sharing agreement.


Get unlimited access to all Global Competition Review content